IP Verse

JAZZ PHARMACEUTICALS IRELAND LIMITED v. INVAGEN PHARMACEUTICALS, INC. - 3:25-cv-15276

Explore the details of the JAZZ PHARMACEUTICALS IRELAND LIMITED v. INVAGEN PHARMACEUTICALS, INC. case under case number 3:25-cv-15276 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
3:25-cv-15276
Filing Date
Sep 4, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
ZYDUS LIFESCIENCES LIMITED -
RK PHARMA, INC. -
APICORE US LLC -
VGYAAN PHARMACEUTICALS LLC -
SANDOZ, INC. -
CIPLA USA, INC. -
MSN LABORATORIES PVT. LTD. -
DR. REDDY'S LABORATORIES, INC. -
ARCHIS PHARMA LLC -
INVAGEN PHARMACEUTICALS, INC. -
PHARMA MAR, S.A. -
JAZZ PHARMACEUTICALS IRELAND LIMITED -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 4, 2025Corporate Disclosure Statement by JAZZ PHARMACEUTICALS IRELAND LIMITED, PHARMA MAR, S.A. identifying Jazz Pharmaceuticals plc as Corporate Parent.. (LIZZA, CHARLES) (Entered: 09/04/2025)PACER Document
Sep 4, 2025Exhibit to 1 Complaint,, Unredacted Complaint by JAZZ PHARMACEUTICALS IRELAND LIMITED, PHARMA MAR, S.A.. (LIZZA, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/04/2025)PACER Document
Sep 4, 2025COMPLAINT against APICORE US LLC, ARCHIS PHARMA LLC, CIPLA (EU) LIMITED, CIPLA LIMITED, CIPLA USA, INC., DR. REDDY'S LABORATORIES, INC., INVAGEN PHARMACEUTICALS, INC., MSN LABORATORIES PVT. LTD., MSN PHARMACEUTICALS INC., RK PHARMA, INC., SANDOZ, INC., VGYAAN PHARMACEUTICALS LLC, ZYDUS LIFESCIENCES GLOBAL FZE, ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC. ( Filing and Admin fee $ 405 receipt number ANJDC-16623705), Related Case Selected, filed by PHARMA MAR, S.A., JAZZ PHARMACEUTICALS IRELAND LIMITED. (Attachments: # 1 Civil Cover Sheet)(LIZZA, CHARLES) (Entered: 09/04/2025)PACER Document